Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial
Robert T. Naismith, Jeffrey A. Cohen, Amit Bar-Or, Giancarlo Comi, Krzysztof W. Selmaj, Hans Peter Hartung
Dive into the research topics of 'Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial'. Together they form a unique fingerprint.